🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: To verify the efficacy and safety of denosumab in the prevention...
Status
Unknown
Location
Nephrology Department of Beijing Jishuitan Hospital
Start Date
2023-01-01
Trial ID
NCT05692297
Treatments Being Tested
A multi-center, randomized, double-blind, parallel controlled Phase III cli...
Status
Completed
Location
Fifth Medical Center of PLA General Hospital
Start Date
2020-03-20
Trial ID
NCT04812509
This is a prospective, single arm phase IIa trial in which patients with ea...
Status
Terminated
Location
Royal Melbourne Hospital
Start Date
2013-07
Trial ID
NCT01864798
Treatments Being Tested
The purpose of the study is to describe the characteristics and management ...
Status
Completed
Location
Amgen
Start Date
2015-06-16
Trial ID
NCT02347865
Treatments Being Tested
Discontinuation of denosumab results in a rebound response of bone turnover...
Status
Completed
Location
251 Hellenic Air Force & VA General Hospital
Start Date
2020-04-01
Trial ID
NCT04338529
Treatments Being Tested
The purpose of this study is to determine if denosumab is non-inferior to z...
Status
Completed
Location
Multiple Locations
Start Date
2006-04-01
Trial ID
NCT00321620
Treatments Being Tested
Aortic stenosis is a condition whereby one of the heart valves (aortic valv...
Status
Completed
Location
Clinical Research Facility University of Edinburgh
Start Date
2014-11-12
Trial ID
NCT02132026
Treatments Being Tested
This is an open-label, single-arm, investigator-initiated study conceived a...
Status
Recruiting
Location
National Cancer Centre Singapore
Start Date
2024-12-09
Trial ID
NCT06513624
Treatments Being Tested
A randomized, double-blind and parallel group study to compare the pharmaco...
Status
Unknown
Location
The First Affiliated Hospital of Jilin University
Start Date
2019-10-31
Trial ID
NCT04213105
This study is a multicenter, randomized, double-blinded, parallel-group Pha...
Status
Completed
Location
Mabwell (Shanghai) Bioscience Co., Ltd.
Start Date
2024-11-16
Trial ID
NCT06804590